Cidara Therapeutics Inc. (CDTX)
20.27
-0.65 (-3.11%)
At close: Jan 15, 2025, 10:48 AM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 35.78M | 32.73M | 62.27M | 35.91M | 60.27M | 74.56M | 75.31M | 104.62M | 107.51M | 22.80M | 185.00K | 1K |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | 14.50M | 19.25M | 44.95M | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 1.05M | 634.00K | 533.00K | 2.02M | 1.10M | 1.27M | 321.00K | 190.00K | 72.00K | 474.00K | 3.00K | n/a |
| Receivables | 16.25M | 5.83M | 5.36M | 11.18M | 10.00K | n/a | 321.00K | n/a | n/a | n/a | n/a | n/a |
| Inventory | 6.10M | 1.00 | -2.59M | n/a | -5.55M | n/a | -321.00K | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 2.73M | 13.06M | 6.66M | 10.10M | 15.54M | 2.57M | 2.04M | 1.56M | 1.41M | 217.00K | 13.00K | n/a |
| Total Current Assets | 60.85M | 45.09M | 71.70M | 57.19M | 65.81M | 77.13M | 77.67M | 105.40M | 108.22M | 23.01M | 198.00K | 1K |
| Property-Plant & Equipment | 5.13M | 1.43M | 2.54M | 1.21M | 2.06M | 712.00K | 1.04M | 1.37M | 1.68M | 863.00K | n/a | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 6.17M | 2.50M | 3.63M | 3.23M | 3.16M | 1.98M | 1.36M | 1.56M | 1.76M | 1.34M | 3.00K | n/a |
| Total Assets | 67.03M | 47.59M | 75.33M | 60.42M | 68.98M | 79.11M | 79.03M | 106.96M | 109.97M | 24.35M | 201.00K | n/a |
| Account Payables | 3.77M | 1.45M | 1.30M | 4.57M | 1.89M | 2.85M | 2.59M | 2.91M | 3.10M | 1.18M | 32.00K | n/a |
| Deferred Revenue | 25.09M | 14.61M | 13.92M | 13.87M | 9.80M | 6.71M | n/a | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | 1.30M | 1.21M | 4.89M | 8.90M | 11.60M | 9.93M | 2.67M | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 19.21M | 12.59M | 13.91M | 11.23M | 6.91M | 7.12M | 6.83M | 6.00M | 2.88M | 2.04M | 84.00K | 80.00K |
| Total Current Liabilities | 67.42M | 29.97M | 34.02M | 38.56M | 30.20M | 19.89M | 12.09M | 8.91M | 5.97M | 3.21M | 116.00K | 80.00K |
| Long-Term Debt | 3.58M | n/a | 1.32M | n/a | 942.00K | n/a | 7.21M | 9.79M | n/a | n/a | 1.48M | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | 81.00K | n/a | 80.00K | 88.00K | 34.00K | n/a | n/a |
| Total Long-Term Liabilities | 7.82M | 20.52M | 19.73M | 11.14M | 942.00K | 81.00K | 7.21M | 9.87M | 6.06M | 34.00K | 1.48M | n/a |
| Total Liabilities | 75.24M | 50.50M | 53.75M | 49.71M | 31.14M | 19.97M | 19.29M | 18.78M | 6.06M | 3.25M | 1.60M | 80.00K |
| Total Debt | 4.88M | 1.32M | 5.06M | 7.96M | 11.72M | 9.93M | 9.87M | 9.79M | n/a | n/a | 1.48M | n/a |
| Common Stock | 9.00K | 7.00K | 7.00K | 4.00K | 3.00K | 3.00K | 2.00K | 2.00K | 1K | n/a | n/a | 1K |
| Retained Earnings | -441.43M | -406.97M | -377.17M | -334.70M | -259.83M | -218.74M | -149.39M | -93.66M | -45.50M | -13.30M | -1.41M | -66.00K |
| Comprehensive Income | n/a | n/a | -0.00 | n/a | n/a | 0.00 | -8.00K | -1K | -8.00K | -179.00K | n/a | n/a |
| Shareholders Equity | -8.21M | -2.90M | 21.57M | 10.71M | 37.84M | 59.14M | 59.74M | 88.18M | 103.91M | 21.10M | -1.40M | -65.00K |
| Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | 14.50M | 19.25M | 44.95M | n/a | n/a | n/a |